Concepedia

Balaji Venugopal

BV

Statistics

Publications

32

Citations

6K

H-Index

22

Active since

2010

Affiliations

Beatson West of Scotland Cancer Centre(Current)

University of Glasgow

Dana-Farber Cancer Institute

University College London

Merck & Co., Inc., Rahway, NJ, USA (United States)

Balaji Venugopal is an author at Beatson West of Scotland Cancer Centre specializing in oncology, medicine, and kidney cancer.

Publications per year

2010–2025

32

Publications

32

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Robert J. Motzer, Konstantin Penkov, John B.A.G. Haanen et al. · New England Journal of Medicine · 2019 · 2.5K citations · Full text

, , +6

Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin

Sarah D. Brown, Paola Nativo, J.L. Smith et al. · Journal of the American Chemical Society · 2010 · 855 citations · Full text

, , +17

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma

Toni K. Choueiri, Piotr Tomczak, Se Hoon Park et al. · New England Journal of Medicine · 2021 · 746 citations · Full text

, , +13

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer

Stephen J. Freedland, Murilo Luz, Ugo De Giorgi et al. · New England Journal of Medicine · 2023 · 291 citations

, , +15

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

Toni K. Choueiri, Piotr Tomczak, Se Hoon Park et al. · New England Journal of Medicine · 2024 · 285 citations · Full text

, , +17

1–5 of 32